Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.
Open | $38.500 |
Close | $38.580 |
Volume / Avg. | 357.017K / 709.358K |
Day Range | 37.650 - 39.100 |
52 Wk Range | 12.570 - 42.500 |
Market Cap | $1.458B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 61 |
Short Interest | 21.02% |
Days to Cover | 19.48 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.
Other companies in Tarsus Pharmaceuticals’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Neumora Therapeutics (NASDAQ:NMRA), ANI Pharmaceuticals (NASDAQ:ANIP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by HC Wainwright & Co. on Monday, May 13, 2024. The analyst firm set a price target for 61.00 expecting TARS to rise to within 12 months (a possible 58.11% upside). 18 analyst firms have reported ratings in the last year.
The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $38.58 last updated Today at May 16, 2024 at 4:06 PM EDT.
There are no upcoming dividends for Tarsus Pharmaceuticals.
Tarsus Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Tarsus Pharmaceuticals.
Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.